A phase I dose escalation study of eryaspase in combination with modified FOLFIRINOX in locally advanced and metastatic pancreatic ductal adenocarcinoma

被引：0
|
作者：
Yin, Chao
Marshall, John
Macke, Laura Ann
He, Aiwu Ruth
Bouker, Kerrie
Weinberg, Benjamin Adam
Mukherji, Reetu
Weiner, Louis M.
Wang, Hongkun
Geng, Xue
Hoke, Frank
Youssoufian, Hagop
El-Hariry, Iman
Noel, Marcus Smith
机构：
[1] Virginia Canc Specialists, Fairfax, VA USA
[2] Georgetown Univ, Lombardi Comprehens Canc Ctr, Ctr Cure Gastrointestinal Canc, Washington, DC USA
[3] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA
[4] Georgetown Univ, Lombardi Comprehens Canc Ctr, Div Hematol & Oncol, Washington, DC USA
[5] Georgetown Univ, Med Ctr, Washington, DC USA
[6] Georgetown Lombardi Comprehens Canc Ctr, Washington, DC USA
[7] Georgetown Univ, Dept Biostat Bioinformat & Biomathemat, Washington, DC USA
[8] Erytech Pharma Inc, Cambridge, MA USA
[9] Brown Univ, Providence, RI USA
[10] Erytech Pharma Inc, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16288
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A phase I dose escalation study of eryaspase in combination with modified FOLFIRINOX in locally advanced and metastatic pancreatic ductal adenocarcinoma.
    Noel, Marcus Smith
    Philip, Philip Agop
    Tejani, Mohamedtaki Abdulaziz
    Marshall, John
    He, Aiwu Ruth
    Weinberg, Benjamin Adam
    Weiner, Louis M.
    Biswas-Baldwin, Nigel
    Hoke, Frank
    Youssoufian, Hagop
    El-Hariry, Iman
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [2] A phase I dose-escalation study of eryaspase in combination with modified FOLFIRINOX in locally advanced and metastatic pancreatic ductal adenocarcinoma: Interim update
    Yin, Chao
    Marshall, John
    Macke, Laura
    Bouker, Kerrie
    He, Aiwu Ruth
    Weinberg, Benjamin Adam
    Weiner, Louis M.
    Wang, Hongkun
    Badri, Nabeel
    Biswas-Baldwin, Nigel
    Hoke, Frank
    Youssoufian, Hagop
    El-Hariry, Iman
    Noel, Marcus Smith
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [3] FOLFIRINOX for locally advanced and metastatic pancreatic ductal adenocarcinoma
    Hisai, Hiroyuki
    Tamaki, Sakurai
    Yuuki, Ikeda
    Yutaka, Koshiba
    Masafumi, Sato
    Ryosuke, Kawasaki
    Hiroshi, Gyobu
    Etsu, Miyazaki
    Tasuku, Hirako
    Shogo, Miura
    ANNALS OF ONCOLOGY, 2015, 26 : 120 - 120
  • [4] FOLFIRINOX for Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma: The Royal Marsden Experience
    Moorcraft, Sing Yu
    Khan, Khurum
    Peckitt, Clare
    Watkins, David
    Rao, Sheela
    Cunningham, David
    Chau, Ian
    CLINICAL COLORECTAL CANCER, 2014, 13 (04) : 232 - 238
  • [5] Phase I Dose-Finding Study of Vandetanib in Combination with Gemcitabine in Locally Advanced Unresectable or Metastatic Pancreatic Adenocarcinoma
    Saletti, Piercarlo
    Sessa, Cristiana
    De Dosso, Sara
    Cerny, Thomas
    Renggli, Verena
    Koeberle, Dieter
    ONCOLOGY, 2011, 81 (01) : 50 - 54
  • [6] A phase Ib dose escalation, safety, and tolerability study of sonidegib in combination with gemcitabine in patients with locally advanced or metastatic pancreatic adenocarcinoma.
    Macarulla, Teresa
    Tabernero, Josep
    Palmer, Daniel H.
    Sharma, Sunil
    Yu, Kenneth H.
    Sellami, Dalila B.
    Zhou, Jocelyn
    Yi, Wu
    Boss, Hildegard
    Kwak, Eunice L.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [7] A phase I radiation dose-escalation study to determine the maximal dose of radiotherapy in combination with weekly gemcitabine in patients with locally advanced pancreatic adenocarcinoma
    Budiharto, Tom
    Haustermans, Karin
    Van Cutsem, Eric
    Van Steenbergen, Werner
    Topal, Baki
    Aerts, Raymond
    Ectors, Nadine
    Bielen, Didier
    Vanbeckevoort, Dirk
    Goethals, Laurence
    Verslype, Chris
    RADIATION ONCOLOGY, 2008, 3 (1)
  • [8] Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer
    Stacey M Stein
    Edward S James
    Yanhong Deng
    Xiangyu Cong
    Jeremy S Kortmansky
    Jia Li
    Carol Staugaard
    Doddamane Indukala
    Ann Marie Boustani
    Vatsal Patel
    Charles H Cha
    Ronald R Salem
    Bryan Chang
    Howard S Hochster
    Jill Lacy
    British Journal of Cancer, 2016, 114 : 737 - 743
  • [9] A phase I radiation dose-escalation study to determine the maximal dose of radiotherapy in combination with weekly gemcitabine in patients with locally advanced pancreatic adenocarcinoma
    Tom Budiharto
    Karin Haustermans
    Eric Van Cutsem
    Werner Van Steenbergen
    Baki Topal
    Raymond Aerts
    Nadine Ectors
    Didier Bielen
    Dirk Vanbeckevoort
    Laurence Goethals
    Chris Verslype
    Radiation Oncology, 3
  • [10] A phase I radiation dose-escalation study to determine the maximal dose of radiotherapy in combination with weekly Gemcitabine in patients with locally advanced pancreatic adenocarcinoma
    Budiharto, T
    Goethals, L
    Verslype, C
    Bielen, D
    Van Stenbergen, W
    Aerts, R
    Topal, B
    Van Cutsem, E
    Haustermans, K
    RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S273 - S273
12345